|
|
|
L’approvisionnement fondé sur la valeur (AFV) est une approche avancée en matière d’achats qui répond à l’épineux problème de savoir comment améliorer les soins...
The Conference Board of Canada | 27 pages |
December 2022
| by Isabelle Gagnon-Arpin, Nicholas Moroz, Chad Leaver
|
|
|
|
|
|
|
In this final instalment of our three-part value-based procurement (VBP) research series, we propose a strategy and recommendations for scaling VBP as a component of value-based...
The Conference Board of Canada | 23 pages |
December 2022
| by Isabelle Gagnon-Arpin, Chad Leaver, Isabella Moroz
|
|
|
|
|
|
|
Dans ce troisième et dernier volet de notre série de travaux de recherche sur l’approvisionnement fondé sur la valeur (AFV), nous proposons une stratégie et des recommandations...
The Conference Board of Canada | 25 pages |
December 2022
| by Isabelle Gagnon-Arpin, Chad Leaver, Isabella Moroz
|
|
|
|
|
|
|
Value-based procurement (VBP) is an advanced approach to purchasing that addresses the challenging problem of how to improve patient care and outcomes while containing healthcare...
The Conference Board of Canada | 27 pages |
October 2022
| by Isabelle Gagnon-Arpin, Chad Leaver, Isabella Moroz, Nicholas Moroz
|
|
|
|
|
|
|
Cette mise à jour du rapport de 2017 du Conference Board du Canada intitulé Understanding the Gap, analyse la disponibilité des couvertures pour les médicaments sur ordonnance...
Le Conference Board du Canada | 23 pages |
August 2022
| by Isabelle Gagnon-Arpin, Wanlin Chen, Chad Leaver
|
|
|
|
|
|
|
L’approvisionnement fondé sur la valeur (AFV) est une approche avancée en matière d’achat qui répond au défi épineux d'améliorer les soins et les résultats pour les...
Le Conference Board du Canada | 15 pages |
August 2022
| by Isabelle Gagnon-Arpin, Chad Leaver, Isabella Moroz, Nicholas Moroz
|
|
|
|
|
|
|
Value-based procurement (VBP) is an advanced approach to purchasing that addresses the challenging problem of how to improve patient care and outcomes while containing healthcare...
The Conference Board of Canada | 14 pages |
August 2022
| by Isabelle Gagnon-Arpin, Isabella Moroz, Nicholas Moroz, Chad Leaver
|
|
|
|
|
|
|
This data briefing, an update to The Conference Board of Canada’s 2017 Understanding the Gap, analyzes the availability of prescription drug coverage across the country and the...
The Conference Board of Canada | 22 pages |
July 2022
| by Isabelle Gagnon-Arpin, Wanlin Chen, Chad Leaver
|
|
|
|
|
|
|
Interprovincial disparities in cancer outcomes persist. This primer explores the potential drivers of these disparities and how we can ensure every Canadian has a chance for the...
The Conference Board of Canada | 32 pages |
July 2022
| by Sarah Lussier Hoskyn, Chad Leaver, Isabella Moroz
|
|
|
|
|
|
|
Les disparités interprovinciales en matière de cancer persistent. Ce condensé explore les facteurs à l’origine de ces disparités et les façons de nous assurer que chaque Canadien...
Le Conference Board du Canada | 36 pages |
July 2022
| by Sarah Lussier Hoskyn, Chad Leaver, Isabella Moroz
|
|
|
|
|
|
|
Aging medical imaging equipment is an ongoing concern in Canada. This issue briefing outlines recent trends impacting the issue and explores ways in which the country can tackle...
The Conference Board of Canada | 24 pages |
May 2022
| by Nicola Waters, Zahra Ahmadvand
|
|
|
|
|
|
|
Cette publication en ligne porte sur l’assurance-médicaments d'ordonnance au Canada et sur l’écart entre les personnes couvertes et les personnes non couvertes.
The Conference Board of Canada | Website |
May 2022
| by Isabelle Gagnon-Arpin
|
|
|
|
|
|
|
This online experience looks at prescription drug insurance in Canada and the gap between the insured and the uninsured.
The Conference Board of Canada | Website |
May 2022
| by Isabelle Gagnon-Arpin
|
|
|
|
|
|
|
Alzheimer’s disease is a growing concern in Canada. Scientific progress is shedding more light on its pathology and opening doors to new treatments. Are Canada’s healthcare systems...
The Conference Board of Canada | 2 pages |
March 2022
| by Isabella Moroz
|
|
|
|
|
|
|
La maladie d'Alzheimer est une préoccupation croissante au Canada. Les progrès scientifiques éclairent davantage sa pathologie et ouvrent les portes à de nouveaux traitements...
Le Conference Board du Canada | 2 pages |
March 2022
| by Isabella Moroz
|
|
|
|
|
|
|
Alzheimer’s disease is a growing concern in Canada. Scientific progress is shedding more light on its pathology and opening doors to new treatments. Are Canada’s healthcare systems...
The Conference Board of Canada | Website |
March 2022
| by Isabella Moroz
|
|
|
|
|
|
|
La maladie d’Alzheimer est un sujet de préoccupation grandissante au Canada. Les progrès scientifiques permettent de mieux comprendre sa pathologie et ouvrent la voie à de nouveaux...
Le Conference Board du Canada | Website |
March 2022
| by Isabella Moroz
|
|
|
|
|
|
|
The current pandemic has provided many lessons on how the design of our built environment contributes to the resilience of communities, both during a crisis and at other times.
The Conference Board of Canada | 22 pages |
February 2022
| by Antonio Gómez Palacio, Pauline Thimm, Roger Francis
|
|
|
|
|
|
|
This briefing looks at potential life years and economic value gained from breakthrough cancer therapies. Gaps in patients’ access to these treatments means lost economic value...
The Conference Board of Canada | 16 pages |
February 2022
| by Kiefer Van Mulligen, Isabella Moroz, Chad Leaver
|
|
|
|
|
|
|
Ce rapport examine les années potentielles de vie et la valeur économique gagnées grâce aux traitements de pointe contre le cancer. Le fossé en matière d’accès des patients à ces...
Le Conference Board du Canada | 17 pages |
February 2022
| by Kiefer Van Mulligen, Isabella Moroz, Chad Leaver
|
|
|
|